[go: up one dir, main page]

LT3500571T - Imidazo[1,2-a]piridino junginiai, juos apimančios kompozicijos, ligų gydymo būdai juos panaudojant, ir jų paruošimo būdai - Google Patents

Imidazo[1,2-a]piridino junginiai, juos apimančios kompozicijos, ligų gydymo būdai juos panaudojant, ir jų paruošimo būdai

Info

Publication number
LT3500571T
LT3500571T LTEP17821743.6T LT17821743T LT3500571T LT 3500571 T LT3500571 T LT 3500571T LT 17821743 T LT17821743 T LT 17821743T LT 3500571 T LT3500571 T LT 3500571T
Authority
LT
Lithuania
Prior art keywords
methods
imidazo
compositions
preparing
treating diseases
Prior art date
Application number
LTEP17821743.6T
Other languages
English (en)
Inventor
Daniel T. STARCZYNOWSKI
Craig J. Thomas
Garrett RHYASEN
Katelyn MELGAR
Morgan MacKenzie WALKER
Jian-kang JIANG
Original Assignee
Children`S Hospital Medical Center
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Children`S Hospital Medical Center, The U.S.A. As Represented By The Secretary, Department Of Health And Human Services filed Critical Children`S Hospital Medical Center
Publication of LT3500571T publication Critical patent/LT3500571T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LTEP17821743.6T 2016-08-17 2017-08-16 Imidazo[1,2-a]piridino junginiai, juos apimančios kompozicijos, ligų gydymo būdai juos panaudojant, ir jų paruošimo būdai LT3500571T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662375965P 2016-08-17 2016-08-17
PCT/US2017/047088 WO2018038988A2 (en) 2016-08-17 2017-08-16 Compounds, compositions, methods for treating diseases, and methods for preparing compounds

Publications (1)

Publication Number Publication Date
LT3500571T true LT3500571T (lt) 2021-04-12

Family

ID=60812120

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP17821743.6T LT3500571T (lt) 2016-08-17 2017-08-16 Imidazo[1,2-a]piridino junginiai, juos apimančios kompozicijos, ligų gydymo būdai juos panaudojant, ir jų paruošimo būdai

Country Status (9)

Country Link
US (1) US20220213094A1 (lt)
EP (2) EP3500571B1 (lt)
CA (1) CA3033755A1 (lt)
DK (1) DK3500571T3 (lt)
ES (1) ES2862314T3 (lt)
LT (1) LT3500571T (lt)
PL (1) PL3500571T3 (lt)
PT (1) PT3500571T (lt)
WO (1) WO2018038988A2 (lt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11542261B2 (en) * 2016-08-17 2023-01-03 Children's Hospital Medical Center Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors
SG11202106582YA (en) * 2018-12-20 2021-07-29 Incyte Corp Imidazopyridazine and imidazopyridine compounds as inhibitors of activin receptor-like kinase-2
JP7712932B2 (ja) * 2019-12-18 2025-07-24 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Lin28の阻害剤及びその使用方法
US20230303563A1 (en) * 2020-07-31 2023-09-28 Children's Hospital Medical Center Multi-cyclic irak and flt3 inhibiting compounds and uses thereof
IL303887A (en) * 2020-12-23 2023-08-01 Childrens Hospital Med Ct Multi-cyclic irak and flt3 inhibiting compounds and uses thereof
WO2023009833A1 (en) * 2021-07-30 2023-02-02 Children's Hospital Medical Center Multi-cyclic irak and flt3 inhibiting compounds and uses thereof
CN118055931A (zh) * 2021-12-23 2024-05-17 杭州多域生物技术有限公司 一种五元并六元化合物、制备方法、药物组合物和应用
CN119698416A (zh) * 2022-06-10 2025-03-25 英特莱治疗公司 作为ripk2抑制剂的咪唑并(1,2-a)吡啶衍生物
WO2023250431A2 (en) * 2022-06-22 2023-12-28 Children's Hospital Medical Center Multi-cyclic irak and flt3 inhibiting compounds and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015076800A1 (en) * 2013-11-21 2015-05-28 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors

Also Published As

Publication number Publication date
ES2862314T3 (es) 2021-10-07
WO2018038988A3 (en) 2018-04-05
EP3854796A1 (en) 2021-07-28
EP3500571B1 (en) 2020-12-30
PL3500571T3 (pl) 2021-06-28
PT3500571T (pt) 2021-03-29
US20220213094A1 (en) 2022-07-07
DK3500571T3 (da) 2021-03-08
EP3500571A2 (en) 2019-06-26
CA3033755A1 (en) 2018-03-01
WO2018038988A2 (en) 2018-03-01

Similar Documents

Publication Publication Date Title
LT3500571T (lt) Imidazo[1,2-a]piridino junginiai, juos apimančios kompozicijos, ligų gydymo būdai juos panaudojant, ir jų paruošimo būdai
IL277576A (en) Mutated pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
IL266170A (en) A process for the preparation of pyrazolo[1,5-a]pyrimidines and their salts
IL265918B (en) Converted pyrazolo[1,5–a]pyridine compounds as ret kinase inhibitors
ZA201802976B (en) N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ZA201800771B (en) Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
ZA201900236B (en) Imidazo[1,2-a]pyridine derivatives, methods for preparing the same and use thereof
ZA201902562B (en) Pyrazolo [1,5-a]pyridine derivatives and their use as pesticides
ZA201808257B (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
ME03427B (me) Pirazolo[1,5-a]pirimidin-5,7-diamin jedinjenja kao cdk inhibitori i njihova terapeutska primjena
EP3250572A4 (en) Substituted imidazo [1, 2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
HUE063998T2 (hu) Imidazo[4,5-b]piridin vegyületek és azok gyógyászati készítményei gyulladásos betegségek kezelésére
ZA201904236B (en) Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as pde1 inhibitors
IL290419B (en) Imidazo[a-1,5]pyrazine derivatives as inhibitors of pi3k delta